Myriad Genetics Inc.

NASDAQ: MYGN · Real-Time Price · USD
5.84
-0.05 (-0.85%)
At close: Aug 15, 2025, 11:39 AM

Myriad Genetics Revenue

Myriad Genetics reported an annual revenue of $837.6M, reflecting a 11.21% growth. For the quarter ending June 30, 2025, Myriad Genetics generated $213.1M in revenue.
Revenue (ttm)
837.6M
Revenue Growth
11.21%
Price / Sales Ratio
1.48
Revenue / Employee
310.22K
Employees
2,700
Market Cap
543.85M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.